Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma

SIMPLE SUMMARY: Patients with endometrial hyperplasia (EH) and endometrial cancer (EC) often fail conservative treatment due to progestin resistance. This article reviews the therapeutic role of progestin in EH and EC as well as the mechanisms of progestin resistance, and systematically expounds pot...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Mu, Chen, Peiqin, Bai, Mingzhu, Huang, Yan, Li, Linxia, Feng, Youji, Liao, Hong, Zheng, Wenxin, Chen, Xiaojun, Zhang, Zhenbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776943/
https://www.ncbi.nlm.nih.gov/pubmed/36551694
http://dx.doi.org/10.3390/cancers14246210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776943/
https://www.ncbi.nlm.nih.gov/pubmed/36551694
http://dx.doi.org/10.3390/cancers14246210

Ejemplares similares